Cargando…

Development and implementation of a continuing medical education program on non-alcoholic fatty liver disease for primary care practitioners in Europe

BACKGROUND: Primary care has a crucial role to play in the prevention, early detection, referral, and risk factor management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis (NAFLD/NASH). In 2021, a team of European collaborators developed a continuing medical education (CME) p...

Descripción completa

Detalles Bibliográficos
Autores principales: Papadakis, Sophia, Anastasaki, Marilena, Gergianaki, Irini, Koek, Ger, Mendive, Juan, Anastasiou, Foteini, Heyens, Leen, Garcia-Retortillo, Montserrat, Muris, Jean, Lionis, Christos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077524/
https://www.ncbi.nlm.nih.gov/pubmed/37035308
http://dx.doi.org/10.3389/fmed.2023.1034626
_version_ 1785020320046907392
author Papadakis, Sophia
Anastasaki, Marilena
Gergianaki, Irini
Koek, Ger
Mendive, Juan
Anastasiou, Foteini
Heyens, Leen
Garcia-Retortillo, Montserrat
Muris, Jean
Lionis, Christos
author_facet Papadakis, Sophia
Anastasaki, Marilena
Gergianaki, Irini
Koek, Ger
Mendive, Juan
Anastasiou, Foteini
Heyens, Leen
Garcia-Retortillo, Montserrat
Muris, Jean
Lionis, Christos
author_sort Papadakis, Sophia
collection PubMed
description BACKGROUND: Primary care has a crucial role to play in the prevention, early detection, referral, and risk factor management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis (NAFLD/NASH). In 2021, a team of European collaborators developed a continuing medical education (CME) program on NAFLD/NASH that consolidates evidence and clinical best practices tailored to the primary care setting. This article reports on the methodology used to design and develop the CME and the results of a feasibility study. METHODS: An expert advisory group representing both European specialists and general practitioners supported the design of the CME to be implemented in three European settings (Greece, Spain, and Netherlands). The CME features four training modules and problem-based learning using clinical case studies. The CME was tested regarding feasibility and acceptability among a sample of primary care providers (PCPs) in Greece (n = 28) with measurements occurring before, immediately after, and 1 month following the training. Outcome measures included satisfaction with the CME, changes in PCPs’ knowledge, attitudes, confidence, and self-reported clinical practices related to NAFLD/NASH. RESULTS: The CME is available as an open-access e-learning course on the European Society for Primary Care Gastroenterology education platform in English, Greek, Spanish, and Dutch. The feasibility study documented high levels of satisfaction, with 96% of PCPs reporting they were extremely or very satisfied with the overall training. Statistically significant increases in PCPs’ confidence in NAFLD/NASH-related clinical practices were documented between the pre- and post-assessments. At the follow-up, 62% of GPs reported that the CME had changed their clinical practices related to NAFLD/NASH to a great extent. CONCLUSION: This CME intervention developed by experts and tailored to PCPs in European settings may serve as an asset for increasing knowledge, confidence, and practice behaviors related to NAFLD/NASH.
format Online
Article
Text
id pubmed-10077524
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100775242023-04-07 Development and implementation of a continuing medical education program on non-alcoholic fatty liver disease for primary care practitioners in Europe Papadakis, Sophia Anastasaki, Marilena Gergianaki, Irini Koek, Ger Mendive, Juan Anastasiou, Foteini Heyens, Leen Garcia-Retortillo, Montserrat Muris, Jean Lionis, Christos Front Med (Lausanne) Medicine BACKGROUND: Primary care has a crucial role to play in the prevention, early detection, referral, and risk factor management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis (NAFLD/NASH). In 2021, a team of European collaborators developed a continuing medical education (CME) program on NAFLD/NASH that consolidates evidence and clinical best practices tailored to the primary care setting. This article reports on the methodology used to design and develop the CME and the results of a feasibility study. METHODS: An expert advisory group representing both European specialists and general practitioners supported the design of the CME to be implemented in three European settings (Greece, Spain, and Netherlands). The CME features four training modules and problem-based learning using clinical case studies. The CME was tested regarding feasibility and acceptability among a sample of primary care providers (PCPs) in Greece (n = 28) with measurements occurring before, immediately after, and 1 month following the training. Outcome measures included satisfaction with the CME, changes in PCPs’ knowledge, attitudes, confidence, and self-reported clinical practices related to NAFLD/NASH. RESULTS: The CME is available as an open-access e-learning course on the European Society for Primary Care Gastroenterology education platform in English, Greek, Spanish, and Dutch. The feasibility study documented high levels of satisfaction, with 96% of PCPs reporting they were extremely or very satisfied with the overall training. Statistically significant increases in PCPs’ confidence in NAFLD/NASH-related clinical practices were documented between the pre- and post-assessments. At the follow-up, 62% of GPs reported that the CME had changed their clinical practices related to NAFLD/NASH to a great extent. CONCLUSION: This CME intervention developed by experts and tailored to PCPs in European settings may serve as an asset for increasing knowledge, confidence, and practice behaviors related to NAFLD/NASH. Frontiers Media S.A. 2023-03-23 /pmc/articles/PMC10077524/ /pubmed/37035308 http://dx.doi.org/10.3389/fmed.2023.1034626 Text en Copyright © 2023 Papadakis, Anastasaki, Gergianaki, Koek, Mendive, Anastasiou, Heyens, Garcia-Retortillo, Muris and Lionis. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Papadakis, Sophia
Anastasaki, Marilena
Gergianaki, Irini
Koek, Ger
Mendive, Juan
Anastasiou, Foteini
Heyens, Leen
Garcia-Retortillo, Montserrat
Muris, Jean
Lionis, Christos
Development and implementation of a continuing medical education program on non-alcoholic fatty liver disease for primary care practitioners in Europe
title Development and implementation of a continuing medical education program on non-alcoholic fatty liver disease for primary care practitioners in Europe
title_full Development and implementation of a continuing medical education program on non-alcoholic fatty liver disease for primary care practitioners in Europe
title_fullStr Development and implementation of a continuing medical education program on non-alcoholic fatty liver disease for primary care practitioners in Europe
title_full_unstemmed Development and implementation of a continuing medical education program on non-alcoholic fatty liver disease for primary care practitioners in Europe
title_short Development and implementation of a continuing medical education program on non-alcoholic fatty liver disease for primary care practitioners in Europe
title_sort development and implementation of a continuing medical education program on non-alcoholic fatty liver disease for primary care practitioners in europe
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077524/
https://www.ncbi.nlm.nih.gov/pubmed/37035308
http://dx.doi.org/10.3389/fmed.2023.1034626
work_keys_str_mv AT papadakissophia developmentandimplementationofacontinuingmedicaleducationprogramonnonalcoholicfattyliverdiseaseforprimarycarepractitionersineurope
AT anastasakimarilena developmentandimplementationofacontinuingmedicaleducationprogramonnonalcoholicfattyliverdiseaseforprimarycarepractitionersineurope
AT gergianakiirini developmentandimplementationofacontinuingmedicaleducationprogramonnonalcoholicfattyliverdiseaseforprimarycarepractitionersineurope
AT koekger developmentandimplementationofacontinuingmedicaleducationprogramonnonalcoholicfattyliverdiseaseforprimarycarepractitionersineurope
AT mendivejuan developmentandimplementationofacontinuingmedicaleducationprogramonnonalcoholicfattyliverdiseaseforprimarycarepractitionersineurope
AT anastasioufoteini developmentandimplementationofacontinuingmedicaleducationprogramonnonalcoholicfattyliverdiseaseforprimarycarepractitionersineurope
AT heyensleen developmentandimplementationofacontinuingmedicaleducationprogramonnonalcoholicfattyliverdiseaseforprimarycarepractitionersineurope
AT garciaretortillomontserrat developmentandimplementationofacontinuingmedicaleducationprogramonnonalcoholicfattyliverdiseaseforprimarycarepractitionersineurope
AT murisjean developmentandimplementationofacontinuingmedicaleducationprogramonnonalcoholicfattyliverdiseaseforprimarycarepractitionersineurope
AT lionischristos developmentandimplementationofacontinuingmedicaleducationprogramonnonalcoholicfattyliverdiseaseforprimarycarepractitionersineurope